| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/01/2006 | CN1739573A Dietotherapeutic nutrient for preventing and treating primary gout and its prepn process |
| 03/01/2006 | CN1739572A Dietotherapeutic nutrient for preventing and treating primary and secondary gout and its prepn process |
| 03/01/2006 | CN1739571A Dietotherapeutic nutrient for preventing and treating non-insulin dependent diabetes and its prepn process |
| 03/01/2006 | CN1739570A Dietotherapeutic nutrient for preventing and treating hyperglycemia and diabetes and its prepn process |
| 03/01/2006 | CN1739569A Dietotherapeutic nutrient for preventing and treating non-insulin independent diabetes and its prepn process |
| 03/01/2006 | CN1739568A Dietotherapeutic nutrient for preventing and treating adipose diabetes and its prepn process |
| 03/01/2006 | CN1739567A Dietotherapeutic nutrient for preventing and treating adipose hyperglycemia and slimming and its prepn process |
| 03/01/2006 | CN1739566A Dietotherapeutic nutrient for preventing and treating hyperglycemia and its prepn process |
| 03/01/2006 | CN1739565A Dietotheraupeutic nutrient for preventing and treating secondary diabetes and its prepn process |
| 03/01/2006 | CN1739564A Dietotherapeutic nutrient for preventing and treating diabetes and its prepn process |
| 03/01/2006 | CN1739561A Application of high permeability medicine composition in preparing pre-nacrosis medicine |
| 03/01/2006 | CN1739560A Dietotherapeutic product for preventing and treating urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739558A Dietotherapeutic product for preventing and treating primary and secondary urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739557A Dietotherapeutic product for preventing and treating primary urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739556A Dietotherapeutic nutrient for preventing and treating secondary gout and its prepn process |
| 03/01/2006 | CN1739555A Dietotherapeutic nutrient for preventing and treating non-insulin dependent hyperglycemia and obesity and its prepn process |
| 03/01/2006 | CN1739554A Dietotherapeutic nutrient for preventing and treating secondary urate calculi and gout and its prepn process |
| 03/01/2006 | CN1739553A Dietotherapeutic nutrient for preventing and treating urate calculi and gout and its prepn process |
| 03/01/2006 | CN1739552A Dietotherapeutic nutrient for treating primary and secondary urate calculi acid gout and its prepn process |
| 03/01/2006 | CN1739551A Dietotherapeutic nutrient for treating primary urate calculi and gout and its prepn process |
| 03/01/2006 | CN1739550A Polycinnamic alcohol injection and its prepn |
| 03/01/2006 | CN1739549A Prepn process of active medicinal lignin matter and its use in treating cardiac vascular diseases |
| 03/01/2006 | CN1739548A Omithogalum caudatum polysaccharide medicine for treating liver cancer |
| 03/01/2006 | CN1739547A Acne treating ointment |
| 03/01/2006 | CN1739546A Use of skullcap aglycone and baicalin in preparing antitumor medicine |
| 03/01/2006 | CN1739545A Pueraria flavone micro pill prepn and its prepn process |
| 03/01/2006 | CN1739544A Chinese medicine prepn fo treating cardiac vascular diseases and its prepn process and quality control method |
| 03/01/2006 | CN1739543A Intravenous injection of antitumor compound nobiliside A and monoacetylated liposome and its prepn |
| 03/01/2006 | CN1739542A Slowly releasing solid ivermectin microballoon prepn |
| 03/01/2006 | CN1739541A Puerarin prepn for eye and its prepn process |
| 03/01/2006 | CN1739540A Application of arctiin in preparing medicine for treating rhinitis and nasosinusitis |
| 03/01/2006 | CN1739539A Use of puerarin in preparing medicine for treating myopia |
| 03/01/2006 | CN1739538A Suppository for teating mycotic vaginitis |
| 03/01/2006 | CN1739537A Cyclodextrin clathrate of breviscapine and its prepn |
| 03/01/2006 | CN1739536A Compound prepn containing monopotassium glycyrrhizunate and its prepn and application |
| 03/01/2006 | CN1739535A Notoginseng seponin-sodium chloride injection and its prepn |
| 03/01/2006 | CN1739534A Compound medicine prepn of ginseng stem and leaf total saponin and propolis total flavone for treating gastropathy |
| 03/01/2006 | CN1739533A Oral disintegrating notoginseng total saponin tablet and its prepn process |
| 03/01/2006 | CN1739532A American ginseng-gynostemma pentaphylla total saponin prepn |
| 03/01/2006 | CN1739531A Ferric saccharate injection for treating iron-deficiency anemia and its prepn process |
| 03/01/2006 | CN1739530A Aspirin-Al-lysine for injection |
| 03/01/2006 | CN1739529A Application of fritillarine and its derivatives in preparing medicine for relieving cough, eliminating phlegm and relieving asthma |
| 03/01/2006 | CN1739528A Application of monomeric alkaloid extracted from Hubei fritillary bulb in preparing medicine for relieving cough, eliminating phlegm and relieving asthma |
| 03/01/2006 | CN1739527A The use of non-oral androgenic steroids in the manufacture of medicine for improving elevated sex hormone binding globulin levels |
| 03/01/2006 | CN1739526A Prepn process of oral slowly-releasing oleanolic acid |
| 03/01/2006 | CN1739525A Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid |
| 03/01/2006 | CN1739524A Lycopene liposome and its prepn process |
| 03/01/2006 | CN1739523A Orally quick disintegrating lornoxicam composition and its prepn process |
| 03/01/2006 | CN1739522A Slowly releasing allopurinol tablet and its prepn |
| 03/01/2006 | CN1739521A Application of pyrimidone compounds in preparing medicine |
| 03/01/2006 | CN1739520A Sildenafil and its recipe for treating tinnitus and deafness |
| 03/01/2006 | CN1739519A Itraconazole emulsion for injection and its prepn |
| 03/01/2006 | CN1739518A Application of penehyclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739517A Application of penehyclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739516A Application of penehyclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739515A Hydroxycamptothecine injection and its prepn process |
| 03/01/2006 | CN1739514A Oral loratadine disintegrating tablet and its prepn |
| 03/01/2006 | CN1739513A Oral loratadine disintegrating tablet and its prepn |
| 03/01/2006 | CN1739512A Milrinone composition for injection and its prepn |
| 03/01/2006 | CN1739511A Application of penehyliclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739510A Use of sophoridine oxide in preparing anticancer medicine |
| 03/01/2006 | CN1739509A Composite medicine for treating tumor and its application |
| 03/01/2006 | CN1739508A Prepn process of isocollidine for eye |
| 03/01/2006 | CN1739507A Medicine composition for treating mixed infectious disease |
| 03/01/2006 | CN1739506A Autoemulsified albendazole prepn and its prepn process |
| 03/01/2006 | CN1739505A L-ornidazole injection prepn |
| 03/01/2006 | CN1739504A L-ornidazole prepn |
| 03/01/2006 | CN1739503A Compound medicine of ozagrel and its salt and troxerutin |
| 03/01/2006 | CN1739502A Application of benzydalysine in preparing medicine for treating diabetic peripheral neuropathy |
| 03/01/2006 | CN1739501A Coated thioctic acid tablet for treating and controlling diabetic neural lesion |
| 03/01/2006 | CN1739500A (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application |
| 03/01/2006 | CN1739499A (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 03/01/2006 | CN1739498A (-)-epigallocatechin gallate-calcium complex solid dispersion and its prepn and application |
| 03/01/2006 | CN1739497A Prepn process of double-layer catechin microcapsule |
| 03/01/2006 | CN1739496A Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 03/01/2006 | CN1739495A Freeze dried tiopronin powder for injection and its prepn |
| 03/01/2006 | CN1739494A Orally taken self-microemulsified concentrate of all-trans vitamin A acid |
| 03/01/2006 | CN1739493A Dispersive glimepiride tablet and its prepn process |
| 03/01/2006 | CN1739492A Electrostatic self-assembly process of preparing multiple medicine controlled releasing coating in exponential increase characteristic |
| 03/01/2006 | CN1739391A Lead-dispelling health food |
| 03/01/2006 | CN1243779C Hydrophilic polymer derivative having Y shaped branch, its preparation method, combined object with medicine molecule and medical composition containing combined object |
| 03/01/2006 | CN1243773C Process for cross-linking hyaluronic acid to polymers |
| 03/01/2006 | CN1243772C Dauricine polysaccharide, its extraction method and the use of medicine with the compound as active component |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 03/01/2006 | CN1243768C Application of steroid saponin for preventing and curing senile dementia and novel steroid saponin |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 03/01/2006 | CN1243766C -’툷Á€-9-�ÐЧ-9A-Á¬ÈË-9A-©›‘ýå˜öÏAМ•·Ü´ |
| 03/01/2006 | CN1243764C Dieneacetal peroxide glycoside kind derivative and its preparation method and its medicinal composition and use |
| 03/01/2006 | CN1243759C Modified phospholipid of poly alkyl oxygen and its producing process |
| 03/01/2006 | CN1243754C New process for the production of 9-oxa-3,7-diazobicyclic(3.3.1) nonane |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243750C 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders |
| 03/01/2006 | CN1243749C Benzimidazole derivatives |
| 03/01/2006 | CN1243747C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 03/01/2006 | CN1243746C Heterocyclic compound inhibiting angiogenesis |
| 03/01/2006 | CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators |
| 03/01/2006 | CN1243740C Alpha-form or beta-form crystal of acetanilide derivative |
| 03/01/2006 | CN1243736C Process for preparation of 3-spiro'cyclohexam-1, 3'-'3H indolin-2'-one derivatives |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |